LifeStance Health Cash Flow from Investing Activities 2020-2023 | LFST

LifeStance Health cash flow from investing activities from 2020 to 2023. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
LifeStance Health Annual Cash Flow Investing
(Millions of US $)
2023 $-60
2022 $-139
2021 $-194
2020 $-861
2019 $-73
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.817B $1.056B
LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.403B 10.53
Quest Diagnostics (DGX) United States $15.823B 16.35
DaVita (DVA) United States $11.969B 14.87
Chemed (CHE) United States $8.605B 26.67
Encompass Health (EHC) United States $8.603B 22.02
Elanco Animal Health (ELAN) United States $8.391B 21.77
Option Care Health (OPCH) United States $5.187B 19.63
RadNet (RDNT) United States $4.254B 88.58
Amedisys (AMED) United States $3.103B 21.98
Astrana Health (ASTH) United States $2.304B 31.16
Addus HomeCare (ADUS) United States $1.805B 25.83
U.S Physical Therapy (USPH) United States $1.601B 42.84
Pennant (PNTG) United States $0.673B 35.57
Aveanna Healthcare Holdings (AVAH) United States $0.510B 0.00
Atai Life Sciences (ATAI) Germany $0.311B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.028B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00